Telomir Pharmaceuticals, Inc. Common Stock (TELO) — Financial Flexibility Index
Telomir Pharmaceuticals, Inc. Common Stock (TELO) has a Financial Flexibility Index of -2.14x as of March 2026. Free cash flow of $-1.77 Million (operating CF $-1.77 Million minus capex $0.00) represents -2% of total liabilities ($827.31K). Check tangible net worth ratio of Telomir Pharmaceuticals, Inc. Common Sto to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Telomir Pharmaceuticals, Inc. Common Stock Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Telomir Pharmaceuticals, Inc. Common Stock across 5 annual periods. For the full cash flow conversion analysis, see TELO cash flow conversion.
Annual Financial Flexibility Index for Telomir Pharmaceuticals, Inc. Common Stock (2021–2025)
Year-by-year free cash flow to debt coverage for Telomir Pharmaceuticals, Inc. Common Stock. Explore TELO operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.58x | $-3.69 Million | $-3.69 Million | $1.43 Million | ▲ +65.3% |
| 2024 | -7.45x | $-5.07 Million | $-5.07 Million | $680.97K | ▼ -157.6% |
| 2023 | -2.89x | $-3.86 Million | $-3.86 Million | $1.34 Million | ▼ -508.0% |
| 2022 | -0.48x | $-468.66K | $-468.66K | $986.01K | ▲ +45.0% |
| 2021 | -0.86x | $-119.39K | $-119.40K | $138.13K | — |